CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Saudi Arabia”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Saudi Arabia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Saudi Arabia. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the Saudi Arabia, and includes:

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (GlaxoSmithKline, Novartis, Pfizer, Tabuk Pharmaceuticals and Saudi Arabian Pharmaceutical Industries & Medical Appliances Corp) and profiles and SWOT analyses of the major players in the medical device market (Cardinal Health, Fujitsu, AstraZeneca, GE Healthcare, and Kimberly-Clark Corporation)
  • Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Saudi Arabia
  • Porter’s five forces analysis for pharmaceutical and medical devices market of Saudi Arabia
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs
  • Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities and challenges to growth in the Saudi Arabian healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to:

  • Develop business strategies by understanding the trends shaping and driving the Saudi Arabian healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in the Saudi Arabian healthcare market

Table of Contents

1 Table of Contents

1.1 List of Figures

1.2 List of Tables

2 Executive Summary

2.1 Executive Summary – Overview

2.2 Key Highlights

2.3 Key ...

1 Table of Contents

1.1 List of Figures

1.2 List of Tables

2 Executive Summary

2.1 Executive Summary – Overview

2.2 Key Highlights

2.3 Key Events: Saudi Arabian Pharmaceutical History, 2008–2019

2.4 Key Events: Saudi Arabian Pharmaceutical Market

2.5 Key Events: M&A, VC & PE Deals, Global Pharmaceutical Market, 2018–2019

2.6 Key Events: Mergers and Acquisitions

2.7 Country Profile, Saudi Arabia, 2018

3 Overview of Pharmaceutical Market

3.1 Pharmaceutical Market – Overview

3.2 Pharmaceutical Market – Exports

3.3 Pharmaceutical Market – Imports

3.4 Pharmaceutical Market – Market Segments

3.5 Pharmaceutical Market – Supply Channels

3.6 Pharmaceutical Market – Top Five Disease Areas

3.7 Pharmaceutical Market – Major Players

4 Overview of Medical Devices Market

4.1 Medical Device Market – Overview

4.2 Medical Device Market – Top Five Segments

4.3 Medical Device Market – Diagnostic Market

4.4 Medical Device Market – Major Players

5 Pharmaceutical and Medical Device Market – Drivers and Barriers

5.1 Drivers

5.2 Barriers

6 Deal analysis

6.1 Deal Analysis: M&A, VF and PE Deals, Pharmaceutical Market, Saudi Arabia

6.2 Deal Analysis: M&A, VF and PE Deals, Medical Device Market, Saudi Arabia

7 Pharmaceutical and Medical Device Market – Porter’s Five Forces Analysis

7.1 Pharmaceutical Market, Saudi Arabia – Porter’s Five Forces Analysis

7.2 Medical Device Market, Saudi Arabia – Porter’s Five Forces Analysis

8 Market Access

8.1 Overview of Healthcare System, Saudi Arabia

8.1.1 Ministry of Health, Saudi Arabia

8.1.2 Healthcare Transformation, Saudi Arabia

8.2 Reimbursement Process, Saudi Arabia

8.2.1 Overview of Insurance, Saudi Arabia

8.2.2 Healthcare Spending and Medical Products Price Index, Saudi Arabia

8.2.3 Pricing Policies, Saudi Arabia

8.3 Regulatory Landscape, Saudi Arabia

8.3.1 Market Authorization for Pharmaceutical Drugs, Saudi Arabia

8.3.2 Market Authorization for Medical Devices, Saudi Arabia

8.3.3 Pharmaceutical Establishment Regulations, Saudi Arabia

8.3.4 Exports and Imports, Saudi Arabia

8.3.5 Intellectual Property Rights, Patent, Saudi Arabia

8.3.6 Intellectual Property Rights, Trademark, Saudi Arabia

8.3.7 Clinical Trial Regulations, Saudi Arabia

8.3.8 Pharmaceutical Advertising Regulations, Saudi Arabia

8.3.9 Labeling and Packaging Regulations, Saudi Arabia

9 Country Healthcare Landscape

9.1 Healthcare Policy Highlights

9.2 Healthcare Facilities

9.3 Healthcare Parameters

9.4 Environmental Health

9.5 Healthcare Personnel

9.6 Disease Burden

9.7 Healthcare Expenditure

9.7.1 Healthcare Expenditure – Overview

9.7.2 Share of Public and Private Sectors

10 Trade Associations, Saudi Arabia

11 Trade Fairs, Saudi Arabia

12 Opportunities and Challenges

13 Appendix

13.1 Research Methodology

13.1.1 Coverage

13.1.2 Secondary Research

13.1.3 Forecasts

13.1.4 Expert Panel

13.2 Bibliography

13.3 Contact Us

13.4 Disclaimer

List of Tables

Table 1: Opportunities in Pharmaceutical and Biotech Clusters, Saudi Arabia, 2019

Table 2: Pharmaceutical Market, Saudi Arabia, Sales of Patented Drug Products by Major Therapeutic ...

Table 1: Opportunities in Pharmaceutical and Biotech Clusters, Saudi Arabia, 2019

Table 2: Pharmaceutical Market, Saudi Arabia, Sales of Patented Drug Products by Major Therapeutic Class (%), 2010–2015

Table 3: Medical Device Market, Saudi Arabia, Revenue by Segment

Table 4: Nephrology and Urology Device Market, Saudi Arabia, Revenue ($M) and Market Share (%) of Major Companies, 2017

Table 5: Drug Delivery Devices Market, Saudi Arabia, Revenue ($B) and Market Share (%) of Major Companies, 2017

Table 6: Healthcare IT Market, Saudi Arabia, Revenue ($M) and Market Share (%) of Major Players, 2017

Table 7: Ophthalmic Devices, Saudi Arabia, Revenue ($M) and Market Share (%) of Major Companies, 2017

Table 8: Hospital Supplies Market, Saudi Arabia, Revenue ($M) and Market Share (%) of Major Companies, 2017

Table 9: Market Shares of Health Insurance Companies, Saudi Arabia, 2017

Table 10: Total Performance Target, Saudi Arabia, 2019

Table 11: MDMA Evaluation Fees, Saudi Arabia, 2016

Table 12: License Or Renewal Fee ($), 2019, Saudi Arabia

Table 13: Profit Margin (%), 2019, Saudi Arabia

Table 14: Customs Ports, 2015, Saudi Arabia

Table 15: Patent Fees ($), 2019, Saudi Arabia

Table 16: Trademark Fees ($), 2019, Saudi Arabia

Table 17: Label of a Pharmaceutical Product, Saudi Arabia, 2019

Table 18: Minimum Particulars to Appear on Blisters or Strips , Saudi Arabia, 2019

Table 19: Minimum Particulars to Appear on Small Immediate Packaging, Saudi Arabia, 2019

Table 20: Recommendations for Using Color, Saudi Arabia

Table 21: Recommendations for Primary Packaging, Saudi Arabia

Table 22: Recommendations for Secondary Packaging, Saudi Arabia

List of Figures

Figure 1: Pharmaceutical Market, Saudi Arabia, Revenue ($B), 2013–2018

Figure 2: Medical Device Market, Saudi Arabia, Revenue ($B), 2015–2020

Figure 3: Number of Deals (2018–2019) ...

Figure 1: Pharmaceutical Market, Saudi Arabia, Revenue ($B), 2013–2018

Figure 2: Medical Device Market, Saudi Arabia, Revenue ($B), 2015–2020

Figure 3: Number of Deals (2018–2019)

Figure 4: 2018–19 Deal Overview By Region

Figure 5: Country Profile, Saudi Arabia, 2018

Figure 6: Pharmaceutical Market, Saudi Arabia, Revenue ($B), 2011–2018

Figure 7: Pharmaceutical Market, Saudi Arabia, Revenue Forecast ($B), 2019–2025

Figure 8: Pharmaceutical Market, Saudi Arabia, Pharmaceutical Exports

Figure 9: Pharmaceutical Market, Saudi Arabia, Top Export Partners

Figure 10: Pharmaceutical Market, Saudi Arabia, Pharmaceutical Imports

Figure 11: Pharmaceutical Market, Saudi Arabia, Top Import Partners

Figure 12: Innovation Centers, Saudi Arabia, 2019

Figure 13: Biosimilars, Saudi Arabia, 2019

Figure 14: Major OTC Drug Classes (Share %), Saudi Arabia, 2018

Figure 15: Pharmaceutical Market, Supply Chain, Saudi Arabia

Figure 16: Pharmaceutical Market, Saudi Arabia, Sales of Patented Drug Products by Major Therapeutic Class, 2010–2015

Figure 17: Pharmaceutical Market, Major Players, Saudi Arabia

Figure 18: Medical Device Market, Saudi Arabia, Revenue ($B), 2015–2020

Figure 19: Medical Device Market, Saudi Arabia, Revenue Forecast ($B), 2021–2025

Figure 20:Medical Device Market, Saudi Arabia, Revenue by Segment ($B), 2018

Figure 21: Nephrology and Urology Device Market, Saudi Arabia, Revenue ($B), 2015–2022

Figure 22: Nephrology and Urology Device Market, Saudi Arabia, Market Share of Major Players (%),2017

Figure 23: Drug Delivery Devices Market, Saudi Arabia, Revenue ($B), 2015–2022

Figure 24: Drug Delivery Devices Market, Saudi Arabia, Market Share of Major Players (%), 2017

Figure 25: Healthcare IT Market, Saudi Arabia, Revenue ($B), 2015–2022

Figure 26: Healthcare IT Market, Saudi Arabia, Market Share of Major Players (%), 2017

Figure 27: Ophthalmic Devices, Saudi Arabia, Revenue ($B), 2015–2022

Figure 28: Ophthalmic Devices, Saudi Arabia, Market Share of Major Players (%), 2017

Figure 29: Hospital Supplies Market, Saudi Arabia, Revenue ($B), 2015–2022

Figure 30: Hospital Supplies Market, Saudi Arabia, Market Share of Major Companies (%), 2017

Figure 31: Diagnostic Market, Saudi Arabia, Revenue ($B), 2015-2020

Figure 32: Diagnostic Market, Saudi Arabia, Revenue ($B), 2021–2025

Figure 33: Medical Device Market – Major Players

Figure 34: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Saudi Arabia, 2018–2019

Figure 35: Deal Value and Deal Count Sub-Types, Pharmaceutical Market, Saudi Arabia, 2018–2019

Figure 36: M&A Deals by Therapy Area, Pharmaceutical Market, Saudi Arabia, 2018–2019 (by value and by number)

Figure 37: Structure of the Healthcare Sectors, Saudi Arabia

Figure 38: Organizational Chart of Ministry of Health, Saudi Arabia

Figure 39: NTP Strategy to Transform Healthcare, Saudi Arabia, 2018

Figure 40: Formulary Additions, Saudi Arabia

Figure 41: Insurance System of GOSI, Saudi Arabia, 2019

Figure 42: Health Insurance Market, Revenue ($B), Saudi Arabia, 2018

Figure 43: OOP Expenditure (% of total expenditure on health), Saudi Arabia, 2010–2016

Figure 44: Annual Rate of Change (%), Health Price Index, Saudi Arabia, 2010–2018

Figure 45: SFDA, Organizational Structure, Saudi Arabia, 2018

Figure 46: MAA Submission Process, Saudi Arabia

Figure 47: Drug Licensing, Saudi Arabia

Figure 48: Drug Licensing Renewal, Saudi Arabia

Figure 49: Patent Application Process, Saudi Arabia, 2018

Figure 50: Number of Hospitals, Saudi Arabia, 2010–2018

Figure 51: Diagnostic Equipment, Saudi Arabia, 2015–2018

Figure 52: Hospital Beds (per 10,000 population), Saudi Arabia

Figure 53: OBS/Gyn and Pediatric Hospital Beds of MoH (per 10,000 population), Saudi Arabia

Figure 54: Psychiatric Hospital Beds of MoH (per 10,000 population), Saudi Arabia

Figure 55: Life Expectancy (Years), 2010–2018, Saudi Arabia

Figure 56: Immunization Rate (%), 2010–2018, Saudi Arabia

Figure 57: PM2.5 (µg/m3), Saudi Arabia, 2010–2017

Figure 58: CO2 Emissions (Million of Tons), Saudi Arabia, 2010–2018

Figure 59: Physicians (per 10,000 population), Saudi Arabia, 2010–2018

Figure 60: Dentists (per 10,000 population), Saudi Arabia, 2010–2018

Figure 61: Nurses (per 10,000 population), Saudi Arabia, 2010–2018

Figure 62: Pharmacists (per 10,000 population), Saudi Arabia, 2010–2018

Figure 63: Major Causes of Mortality (number of deaths), Saudi Arabia

Figure 64: Major Causes of Male Mortality (number of deaths), Saudi Arabia

Figure 65: Major Causes of Female Mortality (number of deaths), Saudi Arabia

Figure 66: DALYs by Major Disease (‘000), Saudi Arabia

Figure 67: Healthcare Expenditure as Percentage of GDP (%), Saudi Arabia, 2010–2016

Figure 68: Public-Private Share (%), Saudi Arabia, 2010–2016

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports

GlobalData's Pharma eTrack is like having another FTE available to create our first-pass market assessments, at a fraction of the cost

  Glenmark Pharmaceuticals, Inc. USA